Cargando…
CG0009, a Novel Glycogen Synthase Kinase 3 Inhibitor, Induces Cell Death through Cyclin D1 Depletion in Breast Cancer Cells
Glycogen synthase kinase 3α/β (GSK3α/β) is a constitutively active serine/threonine kinase involved in multiple physiological processes, such as protein synthesis, stem cell maintenance and apoptosis, and acts as a key suppressor of the Wnt-β-catenin pathway. In the present study, we examined the th...
Autores principales: | Kim, Hyun Mi, Kim, Choung-Soo, Lee, Je-Hwan, Jang, Se Jin, Hwang, Jung Jin, Ro, Seonggu, Choi, Jene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614906/ https://www.ncbi.nlm.nih.gov/pubmed/23565238 http://dx.doi.org/10.1371/journal.pone.0060383 |
Ejemplares similares
-
Epigenetic Modulation with HDAC Inhibitor CG200745 Induces Anti-Proliferation in Non-Small Cell Lung Cancer Cells
por: Chun, Sung-Min, et al.
Publicado: (2015) -
EHMTI-0009. A particular case of cluster headache
por: Tertan, D, et al.
Publicado: (2014) -
Glycogen synthase kinase 3β and cyclin D1 expression in cervical carcinogenesis
por: Park, Hyunsoo, et al.
Publicado: (2016) -
A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
por: Lee, Hee Seung, et al.
Publicado: (2017) -
Constitutive activation of glycogen synthase kinase-3β correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer
por: Cho, Yu Jin, et al.
Publicado: (2010)